Cargando…
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release
AIM: To determine if cytokine release with a solid phase assay is predictive of adverse responses for a range of therapeutic mAbs. METHODS: Cytokine ELISAs and a multi-array system were used to compare responses generated by different therapeutic mAbs using a solid phase assay. Flow cytometry was em...
Autores principales: | Eastwood, David, Bird, Chris, Dilger, Paula, Hockley, Jason, Findlay, Lucy, Poole, Stephen, Thorpe, Susan J, Wadhwa, Meenu, Thorpe, Robin, Stebbings, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731604/ https://www.ncbi.nlm.nih.gov/pubmed/23701319 http://dx.doi.org/10.1111/bcp.12165 |
Ejemplares similares
-
After TGN1412: Recent developments in cytokine release assays
por: Stebbings, R., et al.
Publicado: (2013) -
Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials — Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm
por: Vessillier, S., et al.
Publicado: (2015) -
TGN1412: From Discovery to Disaster
por: Attarwala, H
Publicado: (2010) -
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
por: Panoskaltsis, Nicki, et al.
Publicado: (2020) -
TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model
por: Weißmüller, Sabrina, et al.
Publicado: (2016)